YIDU TECH (02158) announced that its subsidiary, EVYD Research Private Limited, has successfully won a bid from Singapore Health Services Pte Ltd for the implementation, support, and maintenance of the Dr. Buddy project. The total contract value is approximately SGD 2.278 million. This project represents a significant milestone in the group's expansion into the Singapore market. YIDU TECH is a core driver of intelligent upgrades within China's healthcare system. The group deeply empowers the entire industry chain—encompassing healthcare, pharmaceuticals, insurance, and patients—with smart decision-making solutions, aiming to make precision medicine accessible to everyone. By simulating physicians' clinical decision-making logic, training on actual disease progression data, and repeatedly validating outcomes in real-world settings, the group has developed an AI that truly understands diseases. This provides measurable value to key segments of the healthcare ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the path from molecule to patient, enabling patients to access more affordable precision diagnostics and treatments, and providing public health systems with more scientific support. Through its proprietary system-level intelligence, YIDU TECH is creating a more resilient, compassionate, efficient, and universally accessible future for healthcare.